gynecomastia/fatigue

Lyen an sove nan clipboard la

Chwazi kalite sòt

Paj 1 soti nan 32 rezilta yo

Feminizing Adrenocortical Carcinoma Without Gynecomastia.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Malignant feminizing adrenocortical tumors are exceedingly rare. Their main presentation is gynecomastia. In these estrogen secreting tumors (with or without other adrenocortical hormones) lack of gynecomastia is exceptional as in our case. A 44-year-old man presented with abdominal pain.

Pain, fatigue and depression symptom cluster in survivors of prostate cancer.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Pain, fatigue and depression are common sequelae of a cancer diagnosis. The extent to which these occur together in prostate cancer survivors is unknown. We (i) investigated prevalence of the pain-fatigue-depression symptom cluster and (ii) identified factors associated with

Long-term Efficacy and Safety of Enzalutamide Monotherapy in Hormone-naïve Prostate Cancer: 1- and 2-Year Open-label Follow-up Results.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

BACKGROUND Enzalutamide is an androgen receptor inhibitor with a demonstrated overall survival benefit in metastatic castration-resistant prostate cancer. A phase 2 study of enzalutamide monotherapy in patients with hormone-naïve prostate cancer (HNPC) showed a high response rate for the

Long-Term Antitumor Activity and Safety of Enzalutamide Monotherapy in Hormone Naïve Prostate Cancer: 3-Year Open Label Followup Results.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

OBJECTIVE A phase 2 study of enzalutamide monotherapy in patients with hormone naïve prostate cancer demonstrated high prostate specific antigen response rates at 25 weeks, 1 year and 2 years with minimal effects on total body bone mineral density and favorable safety. In this followup analysis we

Antiandrogen monotherapy: indications and results.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Many patients with prostate cancer for whom hormonal therapy is indicated are still physically and sexually active; quality of life is therefore a vital issue when considering treatment options. Traditional castration-based therapies, although effective, have implications with respect to quality of

Bicalutamide-induced hepatotoxicity: A rare adverse effect.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

METHODS Male, 81 FINAL DIAGNOSIS: Prostate cancer Symptoms: Anorexia • dark urine • joundice • letargy METHODS Casodex Clinical Procedure: - Specialty: Oncology. OBJECTIVE Adverse events of drug therapy. BACKGROUND Bicalutamide is a nonsteroidal anti-androgen used extensively during the initiation

[Anti-thyroid peroxidase in non-neoplastic thyroid pathology].

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Anti-thyroid peroxidase antibodies were prospectively assayed and compared with anti-microsome and anti-thyroglobulin antibodies in 203 patients (188 women, 15 men; mean age 42 +/- 14 years). These patients consulted for hyperthyroidism (n = 42, including 18 with Graves' disease), fumary

Use of cyproterone acetate in prostate cancer.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Cyproterone acetate is a progestational antiandrogen with potent antigonadotropic activity that results in rapid suppression of serum testosterone. Used as a single agent, cyproterone acetate yields a total androgen blockade. It may be combined with low-dose diethylstilbestrol, orchiectomy, or LHRH

[Bronchial carcinoma--an overview].

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

The incidence of lung cancer has exploded in this century. The disease is most commonly diagnosed in the 65-75 year age group but can occur as young as 30 years. Cigarette smoking is usually related to lung cancer in men and the risk of developing lung cancer increases with duration of smoking and

[Primary choriocarcinoma of the bladder: a case report of autopsy].

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

The patient was a 70-year-old male with complaint of macrohematuria at the first visit to our clinic on June 10, 1986. At that time, cystoscopy revealed a thumb sized papillary tumor and a rice sized non papillary tumor, and the biopsy specimen was pathologically diagnosed as undifferentiated

Atypical onset of bicalutamide-induced liver injury.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Anti-androgen therapy is the leading treatment for advanced prostate cancer and is commonly used for neoadjuvant or adjuvant treatment. Bicalutamide is a non-steroidal anti-androgen, used during the initiation of androgen deprivation therapy along with a luteinizing hormone-releasing hormone agonist

[Klinefelter's syndrome: diagnosis and treatment. Case report].

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Klinefelter's syndrome affects 1 in 500 men across all ethnic groups but the diagnosis is often delayed because of substantial variations in clinical presentation. A 26 year-old male came to observation for chronic fatigue. His laboratory data and radiological examination were negative. Examination

Rapid androgen cycling as treatment for patients with prostate cancer.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

OBJECTIVE To investigate the safety and feasibility of rapid androgen cycling for men with progressive prostate cancer. METHODS Schedule 1 included a 4-week induction of androgen depletion, followed by 4-week treatment cycles of a monthly gonadotropin-releasing hormone agonist, testosterone on days

Opioid-induced Endocrinopathy

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Opioid-induced endocrinopathy (OIE) is a condition that affects more Americans than other common comorbid conditions such as heart disease and diabetes combined. It is an important and often unrecognized cause of endocrinopathy, and can result in various clinical manifestations such as sexual

[Androgen deprivation therapy in prostate cancer. Indication and systemic consequences].

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Androgen deprivation therapy (ADT) is effective in prolonging the progression free survival of patients with symptomatic/metastatic prostate cancer (PC). The reduction of clinical symptoms of tumour disease and the reduction of tumour growth and metastatic dissemination is accompanied by systemic

Antre nan paj
facebook nou an

Herbal & Natural Medicine

Baz done ki pi konplè remèd fèy medsin te apiye nan syans

Travay nan 55 lang
Geri èrbal te apiye nan syans
Remèd fèy rekonesans pa imaj
Kat entèaktif GPS - tag zèb sou kote (vini byento)
Li piblikasyon syantifik ki gen rapò ak rechèch ou an
Search remèd fèy medsin pa efè yo
Izeganize enterè ou yo ak rete kanpe fè dat ak rechèch la nouvèl, esè klinik ak rive

Tape yon sentòm oswa yon maladi epi li sou remèd fèy ki ta ka ede, tape yon zèb ak wè maladi ak sentòm li itilize kont.
* Tout enfòmasyon baze sou rechèch syantifik pibliye